Metabolic Research, Inc. (OTCBB: MTBR) announced today that an animal study conducted in cooperation with Cornerstone Pharmaceuticals, Inc. of Cranbury, NJ, confirmed that "ABL-SA" protein found in a Brazilian mushroom (a key component in Metabolic Research's Polimmune ™ supplement) is effective in avidly binding to particularly aggressive lung cancer cells called H460, in mice.
